Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors

L Bagnasco, D Piras, S Parodi, I Bauer… - Current cancer drug …, 2012 - ingentaconnect.com
Angiogenesis is a key factor in the carcinogenesis process. In oncological practice,
angiogenesis inhibition, mainly through the blockade of the VEGF family and its receptors …

Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors

L Bagnasco, D Piras, S Parodi… - … cancer drug targets, 2012 - pubmed.ncbi.nlm.nih.gov
Angiogenesis is a key factor in the carcinogenesis process. In oncological practice,
angiogenesis inhibition, mainly through the blockade of the VEGF family and its receptors …

[PDF][PDF] Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors

L Bagnasco, D Piras, S Parodi, I Bauer… - Current Cancer Drug …, 2012 - academia.edu
Angiogenesis is a key factor in the carcinogenesis process. In oncological practice,
angiogenesis inhibition, mainly through the blockade of the VEGF family and its receptors …

Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.

L Bagnasco, D Piras, S Parodi, I Bauer… - Current Cancer Drug …, 2012 - europepmc.org
Angiogenesis is a key factor in the carcinogenesis process. In oncological practice,
angiogenesis inhibition, mainly through the blockade of the VEGF family and its receptors …